Alex Karnal: GLP-1 medicines could exceed $100 billion in revenue, a trillion-dollar public health revolution is imminent, and managing glucose levels is key to reducing cardiovascular risks | Invest Like the Best

GLP-1 medicines are set to revolutionize public health with over $100 billion in annual revenue potential. The post Alex Karnal: GLP-1 medicines could exceed $100 billion in revenue, a trillion-dollar public health revolution is imminent, and managing glucose levels is key to reducing cardiovascular risks | Invest Like the Best appeared first on Crypto Briefing.